Table 3.
Statistical analyses of serum ALDH1A1, LGR5 and β-catenin levels (pg/ml) in control group and BC patients group.
| Control group | Breast cancer patients group | ||
|---|---|---|---|
| Serum ALDH1A1 | Range | 17–21 | 20.5–35.5 |
| Mean ± SE | 19.8 ± 0.4 | 25.97 ± 0.6 | |
| P | < 0.001* | ||
| Serum LGR5 | Range | 22–30.5 | 28–46 |
| Mean ± SE | 26.4 ± 0.8 | 36.2 ± 0.7 | |
| P | < 0.001* | ||
| Serum β-catenin | Range | 119.5–170 | 163.5–232.5 |
| Mean ± SE | 137.7 ± 4.7 | 192.9 ± 3.1 | |
| P | < 0.001* |
P P value for comparing between control group and BC patients group.
*Statistically significant difference at P ≤ 0.05.